Debiopharm

213 articles about Debiopharm

• Debiopharm Presents Positive Preliminary Results From Phase 1 Trials In The Development Of The IAP Inhibitor Debio 1143 At The 27th EORTC-National Cancer Institute-AACR Symposium In Boston

  11/3/2015

• The Japanese Cancer Association And Debiopharm Announce Winners Of The 2015 JCA-Mauvernay Award

  10/9/2015

• Debiopharm And Solid Biosciences, LLC, Announce A Collaboration To Explore The Use Of Alisporivir (Debio 025) In Muscular Dystrophy

  9/8/2015

• Debiopharm Acquires FibroTrap Sample Processing Technology From Spinomix

  6/16/2015

• Debiopharm Announces Phase III Positive Results For Triptorelin 6-Month Formulation In The Management Of Central Precocious Puberty (CPP)

  5/19/2015

• Debiopharm Initiates Clinical Phase II Study Evaluating Debio 1450 In Staphylococcal Skin Infections

  4/23/2015

• Debiopharm Announces Results Of 2 Key Oncology Programs At 2015 American Association for Cancer Research Conference

  4/16/2015

• Debiopharm Regains Full Rights To Alisporivir Program

  1/12/2015

• FDA Grants Fast Track Designation To Debiopharm's Antibiotic Debio 1450

  1/8/2015

• Presented By The Japanese Cancer Association And Debiopharm Group™, The 'JCA-Mauvernay Award 2014' Goes To Doctors Hara And Shibata

  9/29/2014

• Debiopharm And Nobelex Biotech Start Two Collaborations On Development Of New Antibiotics Against N. Gonorrhoeae And Enteric Species

  6/26/2014

• Debiopharm And TCG Lifesciences Announce Successful Completion Of First Phase Of Research Collaboration On Discovery Of Novel Antibiotics

  6/24/2014

• Debiopharm Announces Initiation Of A Phase I Study Of Debio 1450, An IV/Oral Potent Antibiotic Active Against Staphylococcal Infections

  6/19/2014

• Debiopharm Moves Forward Three Of Its Oncology Clinical Programs And Will Present The Recent Progresses At The 50th American Society of Clinical Oncology Annual Meeting

  5/28/2014

• Orient Europharma Co., Ltd. And Debiopharm Announce Their Partnership And The Launch Of Pamorelin®LA In Singapore

  5/27/2014

• Debiopharm And Yale University Extend And Broaden Their Collaboration For The Discovery And Development Of MIF Inhibitors To Treat Autoimmune And Inflammatory Diseases

  5/6/2014

• Curis, Inc. And Debiopharm Report Preclinical Data For Debio 0932 At American Association for Cancer Research Annual Meeting 2014

  4/8/2014

• Evotec AG And Debiopharm To Collaborate On Development Of New Treatment For Cancer

  4/2/2014

• Debiopharm To Acquire Products Or Companies To Expand Activities At Manufacturing Facility In Martigny (Valais, Switzerland)

  3/6/2014

• Debiopharm To Acquire Affinium Pharmaceuticals's Antibiotic Clinical Assets And Platform To Identify And Develop Targeted Antibiotics

  2/10/2014